Thorac Cardiovasc Surg 2004; 52(3): 141-146
DOI: 10.1055/s-2004-820868
Original Cardiovascular

© Georg Thieme Verlag KG Stuttgart · New York

Correction of Congenital Heart Defects in Jehovah's Witness Children[*]

V. Alexi-Meskishvili1 , B. Stiller1 , A. Koster1 , W. Böttcher1 , M. Hübler1 , J. Photiadis1 , P. E. Lange1 , R. Hetzer1
  • 1Department of Cardiothoracic and Vascular Surgery and Department of Congenital Heart Defects, Deutsches Herzzentrum Berlin, Berlin, Germany
Further Information

Publication History

Received January 11, 2004

Publication Date:
11 June 2004 (online)

Abstract

Between August 1989 and July 2003 14 Jehovah's Witness children with congenital heart defects (CHD) aged under 14 years (median 2.9 years) and with a median weight of 14 kg underwent 16 operations with cardiopulmonary bypass (CPB). Five children had been operated on previously between one to three times. Preoperatively, 7 children were prepared with oral iron supplementation and 10 recieved erythropoietin. Mean hemoglobin (Hb) at admission was 14.4 g/dl (range 10.9 - 19.2). The cardiopulmonary bypass (CPB) circuit was modified to reduce total priming volume. High doses of aprotinin were administered. The modified ultrafiltration (MUF) circuit, used in 7 patients, was parallel to the ECC circuit with continuous circulation of the blood through a small shunt between the arterial and venous lines. Operations performed consisted of VSD closure (3 pts.), ASD closure (3 pts.), Fontan operation (2 pts.), and complete AV canal correction, aortic commissurotomy, Ross operation, Glenn shunt, cor triatriatum correction, MV reconstruction combined with left outflow tract stenosis resection, correction of absent pulmonary valve syndrome, and correction of tetralogy of Fallot in one patient each. There were no deaths. Mean duration of CPB was 192 min and mean aortic cross-clamp time 40 min. The Hb value at the end of the operation was 4.9 - 14.5 g/dl (mean 9.6) and at discharge it was 7.1 - 14.5 g/dl (mean 15.5). No blood or blood products were used in any patient.

Conclusion: Bloodless cardiac surgery with and without CPB can be safely performed in Jehovah's Witness infants and children.

1 Presented at the Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery, Hamburg, February 17, 2003

References

  • 1 Cooley D, Crawford F, Howell J, Beall A J. Open heart surgery in Jehovah's Witness.  Am J Cardiol. 1964;  13 779-781
  • 2 Alexi-Meskishvili V, Ovroutski S, Fischer T. Correction of cor triatriatum sinistrum in a Jehovah's Witness infant.  Eur J Cardiothorac Surg. 2000;  18 724-726
  • 3 Rosengart T. Cardiac surgery in Jehovah's Witness. Krieger K, Isom O Blood Conservation in Cardiac Surgery. New York; Springer-Verlag 1998: 159-167
  • 4 Röttgers H, Nedjat S. Kritik am Transfusionsverbot nimmt zu.  Deutsches Ärzteblatt. 2002;  3 102-105
  • 5 Schmid D, Krempel S, Scheld H. Jehovah's Whitnesses - how to encounter the transfusion issue.  Thorac Cardiovasc Surg. 2002;  20 380-383
  • 6 Jones J, Cullough L, Richmann B. A surgeon's obligations to a Jehovah's Witness child.  Surgery. 2002;  133 110-111
  • 7 Court of Appeal C, Ontario. R. B. and Children's Aid Society of Metropolitan Toronto.  Dom Law Rep. 1992;  96 45-85
  • 8 Court of Appeal N Y. Fosmire vs. Nicolau.  North East Rep Second Ser. 1990;  551 77-89
  • 9 Henling C, Carmichael M, Keats A, Cooley D. Cardiac operations for congenital heart disease in children of Jehovah's Witnesses.  J Thorac Cardiovasc Surg. 1985;  89 914-920
  • 10 Jonas R, Wypij D, Troth S, Bellinger D, Visconti K, du Plessis A. et al . The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of randomized trial in infants.  J Thorac Cardiovasc Surg. 2003;  126 1765-1772
  • 11 Kawamura M, Minamikawa O, Yokochi K, Maki S, Yasuda T, Mizukawa Y. Safe limit of hemodilution in cardiopulmonary bypass. Comparative analysis between cyanotic and acyanotic congenital heart disease.  Jpn J Surg. 1980;  10 206-211
  • 12 Forest R, Groom R, Quinn R, Donnelly J, Clark C. Repair of hypoplastic left heart syndrome of a 4. 25-kg Jehovah's Witness.  Perfusion. 2002;  17 221-225
  • 13 Lewis C, Murphy M, Cooley D. Risk factors for cardiac operations in adult Jehovah's Witness.  Ann Thorac Surg. 1991;  51 448-450
  • 14 van Son J, Hovaguimian H, Rao I, He G W, Meiling G, King D. et al . Strategies for repair of congenital heart defects in children without the use of blood.  Ann Thorac Surg. 1995;  59 384-388
  • 15 Rosengart T, Helm R, Klemperer J, Krieger K, Isom O. Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses.  Ann Thorac Surg. 1994;  58 1397-1403
  • 16 Jahangiri M, Rayner A, Keogh B, Lincoln C. Cerebrovascular accident after vacuum-assisted venous drainage in a Fontan patient: a cautionary tale.  Ann Thorac Surg. 2001;  72 1727-1728
  • 17 Tsang V, Mullaly R, Ragg P, Karl T, Mee R. Bloodless open-heart surgery in infants and children.  Perfusion. 1994;  9 257-263
  • 18 Bando K, Vijay P, Turrentine M, Sharp T, Means L. et al . Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study.  J Thorac Cardiovasc Surg. 1998;  115 517-527
  • 19 Codispoti M, Ludlam C, Simpson D, Mankad P. Individualized heparin and protamine management in infants and children undergoing cardiac operations.  Ann Thorac Surg. 2001;  71 922-927
  • 20 Despotis G, Levine V, Saleem R, Spitznagel E, Joist J. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial.  Lancet. 1999;  354 1124-1125

1 Presented at the Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery, Hamburg, February 17, 2003

V. Alexi-Meskishvili

Deutsches Herzzentrum Berlin

Augustenburger Platz 1

13353 Berlin

Germany

Phone: + 493045932010

Fax: + 49 30 45 93 21 10

Email: alexi@dhzb.de

    >